Combination DCV/SOF is Effective in Achieving Sustained Response in Patients with HCV GT-3

Article Figures & Data

Figures

  • Figure 1.

    Primary End Point: Sustained Viral Response to Treatment 12 Weeks After Therapy

    Error bars indicate 95% confidence intervals. SVR12, sustained viral response to treatment 12 weeks after therapy. aHepatitis C virus RNA < lower limit of quantification (25 IU/mL).Reproduced with permission from DR Nelson, MD.
  • Figure 2.

    On-Treatment Virologic Response

    HCV, hepatitis C virus; LLOQ, lower limit of quantification; SVR12, sustained viral response to treatment 12 weeks after therapy. aUndetectable HCV RNA or HCV RNA < LLOQ (25 IU/mL). bSVR12 rates based on week 4 HCV RNA levels: < LLOQ, target detected, 86%; < LLOQ, target not detected, 91%.Reproduced with permission from DR Nelson, MD.